MedTrace Logo

Turmeric Efficacy for Mobility and Joint Function

NCT04506411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2023-05-03

No results posted yet for this study

Summary

The objective of the study is to test the capacity of a 12-weeks Turmipure GOLD® supplementation to reduce joint discomfort.

Conditions

Interventions

DIETARY_SUPPLEMENT

Turmipure GOLD®

TPG: Turmipure GOLD® capsules - 4 capsules once daily- as prescribed

DIETARY_SUPPLEMENT

Turmeric rhizome PE 95% curcuminoids

STE: Turmeric rhizome PE 95% curcuminoids - 4 capsules once daily- as prescribed

DIETARY_SUPPLEMENT

Placebo

Placebo: Maltodextrin - 4 capsules once daily- as prescribed

Sponsors & Collaborators

  • Artialis

    collaborator INDUSTRY

  • Vizera d.o.o.

    collaborator INDUSTRY

  • Givaudan France Naturals

    lead INDUSTRY

Principal Investigators

  • Matija Tomšič, Prof., MD · Univerzitetni klinični center Ljubljana, Klinični oddelek za revmatologijo, Ljubljana, Slovenia

  • Samo K Fokter, MD · Univerzitetni klinični center Maribor, Oddelek za ortopedijo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-24
Primary Completion
2023-03-03
Completion
2023-03-03

Countries

  • Croatia
  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04506411 on ClinicalTrials.gov